Attached files

file filename
EX-99.1 - EX-99.1 - BODY CENTRAL CORPa12-2448_1ex99d1.htm

 

 

SECURITIES AND EXCHANGE COMMISSION

UNITED STATES

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)  January 9, 2012

 

Body Central Corp.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-34906

 

14-1972231

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

6225 Powers Avenue

Jacksonville, FL

 

32217

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number including area code:  (904)- 737-0811

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230 .425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 7.01:                                         Regulation FD Disclosure.

 

On January 9, 2012, the Company issued a press release announcing the Company’s sales results for the fourth quarter 2011 and expectations relating to its EPS guidance for the fourth quarter and full fiscal year 2011, ending December 31, 2011. The Company is furnishing a copy of the press release hereto as Exhibit 99.1.

 

The information in this item shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference into any disclosure document relating to the Company, except to the extent, if any, expressly set forth by specific reference in such filing.

 

Item 9.01:                                         Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit 99.1

 

Press release of Body Central Corp. dated January 9, 2012

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

BODY CENTRAL CORP.

 

(registrant)

 

 

 

 

January 9, 2012

 

By:

/s/ Tom Stoltz

 

 

Tom Stoltz

 

 

Executive Vice President and Chief Financial

 

 

Officer

 

3